Page 389 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 389
Ophthalmologic and Neuro-Ophthalmologic Aspects of Vasculitides 363
[81] Font RL, Mehta RS, Streusand SB, et al. Bilateral retinal ischemia in Kawasaki disease.
Postmortem findings and electron microscopic observations. Ophthalmol. 1983;
90:569-577.
[82] Verghote M, Roussea E, Jacob J, LaPointe N. An uncommon clinical sign in
mucocutaneous lymph node syndrome. Acta. Paediatr. Scand., 1981; 70:591-593.
[83] Anand S, Yang TC. Optic disc changes in KD. J. Ped. Ophthalmol. Strabismus.
2004:41:177-179.
[84] Son MB, Gauvreau K, Burns JC, et al. Infliximab for intravenous immunoglobulin
resistance in KD: a retrospective study. J. Pediatr., 2011; 158:644.
[85] Dominguez SR, Anderson MS. Advances in the treatment of KD. Curr. Opin. Pediatr.
2013; 25:103-109.
[86] Kadyan A, Choi J, Headon MP. Disciform keratitis and optic disc swelling in Kawasaki
disease: an unusual presentation. Eye, 2006; 20:976-977.
[87] Rennebohm RM, Burke MJ, Crowe W, et al. Anterior uveitis in Kawasaki?s disease.
Am. J. Ophthalmol., 1981; 91:535-537.
[88] Mahr A, Guillevin L, Poissonnet M, et al. Prevalences of polyarteritis nodosa,
microscopic polyangiitis, Wegener?s granulomatosis, and Churg-Strauss syndrome in a
French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis
Rheum. 2004; 51:92-99.
[89] Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-
year study in the United Kingdom. Arthritis Rheum. 2000;43:414–419.
[90] Koldingsnes W, Nossent H. Epidemiology of Wegener?s granulomatosis in northern
Norway. Arthritis Rheum. 2000;43:2481–2487.
[91] Leavitt R, Fauci A, Bloch D, et al. The American college of rheumatology 1990 criteria
for the classification of Wegener?s granulomatosis. Arthritis and Rheum. 1990;
33:1101-1107.
[92] Akikusa JD, Schneider R, Harvey EA, et al. Clinical features and outcome of pediatric
Wegener?s granulomatosis. Arthritis and Rheum. 2007; 57:837-844.
[93] McDonald J, Edwards R, Wegener?s granulomatosis- a triad. JAMA, 1960; 173:1205–
1209.
[94] Shiuey Y, Foster CS. Peripheral ulcerative keratitis and collagen vascular disease. Int.
Ophthalmol. Clin. 1998; 38:21-32.
[95] Bullen CL, Liesegang TJ, McDonald TJ, et al. Ocular complications of Wegener?s
granulomatosis. Ophthalmology, 1983; 90:279-290.
[96] Hoffman G, Kerr G, Leavitt R, et al. Wegener Granulomatosis: an analysis of 158
patients. Ann. Int. Med., 1992; 116:488-498.
[97] Fauci AS, Haynes BF, Katz P, et al. Wegener?s granulomatosis: prospective clinical
and therapeutic experience with 85 patients for 21 years. Ann. Int. Med., 1983; 98:76-
85.
[98] Chan A, Li E, Choi P, et al. Unusual eye signs in Wegener?s granulomatosis. Hong
Kong Med. J., 2007; 13:241-242.
[99] Perry SR, Rootman J, White VA. The clinical and pathological constellation of
Wegener granulomatosis of the orbit. Ophthalmology, 1997; 104:683–694.
[100] Sadiq SA, Jenning CR, Jones NS, et al. Wegener?s granulomatosis: the ocular
manifestations revisited. Orbit, 2000; 19:253–261.
Complimentary Contributor Copy
